Num | GO | Overlap | Size | P Value | Adj. P Value |
1 |
BIOLOGICAL ADHESION |
32 |
1032 |
6.907e-15 |
3.214e-11 |
2 |
IMMUNE SYSTEM PROCESS |
43 |
1984 |
1.639e-14 |
3.785e-11 |
3 |
POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS |
29 |
867 |
2.441e-14 |
3.785e-11 |
4 |
REGULATION OF CELL ADHESION |
25 |
629 |
4.369e-14 |
5.083e-11 |
5 |
LEUKOCYTE ACTIVATION |
21 |
414 |
5.594e-14 |
5.206e-11 |
6 |
POSITIVE REGULATION OF RESPONSE TO STIMULUS |
41 |
1929 |
1.644e-13 |
1.275e-10 |
7 |
LYMPHOCYTE ACTIVATION |
19 |
342 |
1.979e-13 |
1.315e-10 |
8 |
CELL ACTIVATION |
23 |
568 |
3.545e-13 |
2.062e-10 |
9 |
REGULATION OF RESPONSE TO STRESS |
35 |
1468 |
6.728e-13 |
3.478e-10 |
10 |
POSITIVE REGULATION OF CELL ADHESION |
19 |
376 |
1.064e-12 |
4.5e-10 |
11 |
REGULATION OF IMMUNE SYSTEM PROCESS |
34 |
1403 |
1.001e-12 |
4.5e-10 |
12 |
REGULATION OF CELL CELL ADHESION |
19 |
380 |
1.282e-12 |
4.971e-10 |
13 |
SINGLE ORGANISM CELL ADHESION |
20 |
459 |
3.876e-12 |
1.202e-09 |
14 |
LEUKOCYTE MIGRATION |
16 |
259 |
3.677e-12 |
1.202e-09 |
15 |
RESPONSE TO OXYGEN CONTAINING COMPOUND |
33 |
1381 |
3.476e-12 |
1.202e-09 |
16 |
REGULATION OF HOMOTYPIC CELL CELL ADHESION |
17 |
307 |
4.286e-12 |
1.246e-09 |
17 |
IMMUNE SYSTEM DEVELOPMENT |
22 |
582 |
4.788e-12 |
1.31e-09 |
18 |
POSITIVE REGULATION OF CELL ACTIVATION |
17 |
311 |
5.267e-12 |
1.362e-09 |
19 |
REGULATION OF CELL PROLIFERATION |
34 |
1496 |
6.004e-12 |
1.47e-09 |
20 |
REGULATION OF CELL ACTIVATION |
20 |
484 |
1.014e-11 |
2.358e-09 |
21 |
LOCOMOTION |
29 |
1114 |
1.25e-11 |
2.769e-09 |
22 |
REGULATION OF CELL DEATH |
33 |
1472 |
1.939e-11 |
4.101e-09 |
23 |
REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
35 |
1656 |
2.072e-11 |
4.192e-09 |
24 |
REGULATION OF CELLULAR COMPONENT MOVEMENT |
24 |
771 |
2.672e-11 |
5.181e-09 |
25 |
NEGATIVE REGULATION OF CELL DEATH |
25 |
872 |
5.596e-11 |
1.041e-08 |
26 |
POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
25 |
876 |
6.166e-11 |
1.103e-08 |
27 |
POSITIVE REGULATION OF LOCOMOTION |
18 |
420 |
6.714e-11 |
1.157e-08 |
28 |
POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
31 |
1395 |
1.16e-10 |
1.927e-08 |
29 |
CELL MOTILITY |
24 |
835 |
1.373e-10 |
2.129e-08 |
30 |
LOCALIZATION OF CELL |
24 |
835 |
1.373e-10 |
2.129e-08 |
31 |
LEUKOCYTE DIFFERENTIATION |
15 |
292 |
2.44e-10 |
3.663e-08 |
32 |
MOVEMENT OF CELL OR SUBCELLULAR COMPONENT |
29 |
1275 |
3.109e-10 |
4.521e-08 |
33 |
RESPONSE TO OXIDATIVE STRESS |
16 |
352 |
3.569e-10 |
5.032e-08 |
34 |
CELLULAR RESPONSE TO ORGANIC SUBSTANCE |
35 |
1848 |
4.225e-10 |
5.783e-08 |
35 |
LYMPHOCYTE COSTIMULATION |
9 |
78 |
9.583e-10 |
1.239e-07 |
36 |
HOMEOSTATIC PROCESS |
29 |
1337 |
9.365e-10 |
1.239e-07 |
37 |
RESPONSE TO ENDOGENOUS STIMULUS |
30 |
1450 |
1.37e-09 |
1.723e-07 |
38 |
POSITIVE REGULATION OF CELL CELL ADHESION |
13 |
243 |
2.528e-09 |
3.096e-07 |
39 |
CELL CELL ADHESION |
19 |
608 |
3.776e-09 |
4.505e-07 |
40 |
CELL DEVELOPMENT |
29 |
1426 |
4.079e-09 |
4.745e-07 |
41 |
ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY |
20 |
689 |
4.912e-09 |
5.575e-07 |
42 |
REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
23 |
926 |
5.783e-09 |
6.407e-07 |
43 |
CARDIOVASCULAR SYSTEM DEVELOPMENT |
21 |
788 |
8.676e-09 |
9.175e-07 |
44 |
CIRCULATORY SYSTEM DEVELOPMENT |
21 |
788 |
8.676e-09 |
9.175e-07 |
45 |
REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT |
31 |
1672 |
9.347e-09 |
9.665e-07 |
46 |
RESPONSE TO EXTERNAL STIMULUS |
32 |
1821 |
1.824e-08 |
1.845e-06 |
47 |
RESPONSE TO REACTIVE OXYGEN SPECIES |
11 |
191 |
2.121e-08 |
2.099e-06 |
48 |
IMMUNE RESPONSE |
24 |
1100 |
3.114e-08 |
3.018e-06 |
49 |
CIRCULATORY SYSTEM PROCESS |
14 |
366 |
4.275e-08 |
4.06e-06 |
50 |
LEUKOCYTE CELL CELL ADHESION |
12 |
255 |
4.444e-08 |
4.135e-06 |
51 |
CELL CHEMOTAXIS |
10 |
162 |
4.97e-08 |
4.534e-06 |
52 |
CELLULAR CHEMICAL HOMEOSTASIS |
17 |
570 |
5.337e-08 |
4.7e-06 |
53 |
LYMPHOCYTE DIFFERENTIATION |
11 |
209 |
5.354e-08 |
4.7e-06 |
54 |
PHOSPHORYLATION |
25 |
1228 |
5.892e-08 |
5.077e-06 |
55 |
REGULATION OF BODY FLUID LEVELS |
16 |
506 |
6.141e-08 |
5.195e-06 |
56 |
TISSUE DEVELOPMENT |
28 |
1518 |
6.52e-08 |
5.418e-06 |
57 |
RESPONSE TO LIPID |
21 |
888 |
6.747e-08 |
5.508e-06 |
58 |
REGULATION OF CELL GROWTH |
14 |
391 |
9.671e-08 |
7.759e-06 |
59 |
CELLULAR HOMEOSTASIS |
18 |
676 |
1.15e-07 |
9.068e-06 |
60 |
REGULATION OF DEFENSE RESPONSE |
19 |
759 |
1.286e-07 |
9.977e-06 |
61 |
REGULATION OF ANATOMICAL STRUCTURE SIZE |
15 |
472 |
1.54e-07 |
1.175e-05 |
62 |
REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS |
22 |
1021 |
1.594e-07 |
1.178e-05 |
63 |
REGULATION OF CELLULAR RESPONSE TO STRESS |
18 |
691 |
1.593e-07 |
1.178e-05 |
64 |
PEPTIDYL TYROSINE MODIFICATION |
10 |
186 |
1.821e-07 |
1.324e-05 |
65 |
EPITHELIUM DEVELOPMENT |
21 |
945 |
1.912e-07 |
1.369e-05 |
66 |
CHEMICAL HOMEOSTASIS |
20 |
874 |
2.447e-07 |
1.725e-05 |
67 |
REGULATION OF SEQUESTERING OF CALCIUM ION |
8 |
107 |
2.636e-07 |
1.818e-05 |
68 |
POSITIVE REGULATION OF DEVELOPMENTAL PROCESS |
23 |
1142 |
2.657e-07 |
1.818e-05 |
69 |
EPITHELIAL CELL DIFFERENTIATION |
15 |
495 |
2.832e-07 |
1.91e-05 |
70 |
POSITIVE REGULATION OF LEUKOCYTE MIGRATION |
8 |
109 |
3.042e-07 |
2.022e-05 |
71 |
POSITIVE REGULATION OF CELL PROLIFERATION |
19 |
814 |
3.762e-07 |
2.398e-05 |
72 |
REGULATION OF ION HOMEOSTASIS |
10 |
201 |
3.737e-07 |
2.398e-05 |
73 |
NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
21 |
983 |
3.664e-07 |
2.398e-05 |
74 |
IMMUNOLOGICAL SYNAPSE FORMATION |
4 |
11 |
3.937e-07 |
2.476e-05 |
75 |
INTRACELLULAR SIGNAL TRANSDUCTION |
27 |
1572 |
4.919e-07 |
3.012e-05 |
76 |
REGULATION OF HOMEOSTATIC PROCESS |
14 |
447 |
4.904e-07 |
3.012e-05 |
77 |
LEUKOCYTE CHEMOTAXIS |
8 |
117 |
5.248e-07 |
3.171e-05 |
78 |
REGENERATION |
9 |
161 |
5.533e-07 |
3.301e-05 |
79 |
POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING |
7 |
81 |
5.652e-07 |
3.315e-05 |
80 |
IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY |
12 |
323 |
5.699e-07 |
3.315e-05 |
81 |
HEART MORPHOGENESIS |
10 |
212 |
6.097e-07 |
3.484e-05 |
82 |
VASCULAR PROCESS IN CIRCULATORY SYSTEM |
9 |
163 |
6.139e-07 |
3.484e-05 |
83 |
REGULATION OF PROTEIN KINASE B SIGNALING |
8 |
121 |
6.787e-07 |
3.805e-05 |
84 |
TAXIS |
14 |
464 |
7.652e-07 |
4.239e-05 |
85 |
REGULATION OF IMMUNE RESPONSE |
19 |
858 |
8.32e-07 |
4.399e-05 |
86 |
NEGATIVE REGULATION OF HOMEOSTATIC PROCESS |
8 |
124 |
8.182e-07 |
4.399e-05 |
87 |
PROTEIN PHOSPHORYLATION |
20 |
944 |
8.227e-07 |
4.399e-05 |
88 |
HEART DEVELOPMENT |
14 |
466 |
8.053e-07 |
4.399e-05 |
89 |
POSITIVE REGULATION OF CELL COMMUNICATION |
26 |
1532 |
1.054e-06 |
5.508e-05 |
90 |
DIVALENT INORGANIC CATION HOMEOSTASIS |
12 |
343 |
1.073e-06 |
5.548e-05 |
91 |
RESPONSE TO INORGANIC SUBSTANCE |
14 |
479 |
1.115e-06 |
5.702e-05 |
92 |
REGULATION OF EPITHELIAL CELL PROLIFERATION |
11 |
285 |
1.191e-06 |
6.025e-05 |
93 |
REGULATION OF GROWTH |
16 |
633 |
1.232e-06 |
6.162e-05 |
94 |
POSITIVE REGULATION OF LIPID KINASE ACTIVITY |
5 |
32 |
1.265e-06 |
6.261e-05 |
95 |
RESPONSE TO WOUNDING |
15 |
563 |
1.427e-06 |
6.697e-05 |
96 |
POSITIVE REGULATION OF VASCULATURE DEVELOPMENT |
8 |
133 |
1.392e-06 |
6.697e-05 |
97 |
REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING |
10 |
233 |
1.439e-06 |
6.697e-05 |
98 |
VASCULOGENESIS |
6 |
59 |
1.43e-06 |
6.697e-05 |
99 |
POSITIVE REGULATION OF IMMUNE RESPONSE |
15 |
563 |
1.427e-06 |
6.697e-05 |
100 |
REGULATION OF VASCULATURE DEVELOPMENT |
10 |
233 |
1.439e-06 |
6.697e-05 |
101 |
RESPONSE TO HORMONE |
19 |
893 |
1.507e-06 |
6.944e-05 |
102 |
POSITIVE REGULATION OF T CELL PROLIFERATION |
7 |
95 |
1.676e-06 |
7.646e-05 |
103 |
REGULATION OF ERK1 AND ERK2 CASCADE |
10 |
238 |
1.743e-06 |
7.874e-05 |
104 |
TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY |
14 |
498 |
1.761e-06 |
7.877e-05 |
105 |
ION HOMEOSTASIS |
15 |
576 |
1.891e-06 |
8.379e-05 |
106 |
BLOOD VESSEL MORPHOGENESIS |
12 |
364 |
1.993e-06 |
8.747e-05 |
107 |
REGULATION OF ENDOTHELIAL CELL PROLIFERATION |
7 |
98 |
2.068e-06 |
8.991e-05 |
108 |
REGULATION OF MAPK CASCADE |
16 |
660 |
2.116e-06 |
9.118e-05 |
109 |
MYELOID LEUKOCYTE MIGRATION |
7 |
99 |
2.214e-06 |
9.451e-05 |
110 |
POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS |
25 |
1492 |
2.235e-06 |
9.452e-05 |
111 |
CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
14 |
513 |
2.488e-06 |
0.0001039 |
112 |
REGULATION OF PROTEIN MODIFICATION PROCESS |
27 |
1710 |
2.501e-06 |
0.0001039 |
113 |
ORGAN MORPHOGENESIS |
18 |
841 |
2.704e-06 |
0.0001113 |
114 |
REGULATION OF ACTIN FILAMENT BASED PROCESS |
11 |
312 |
2.864e-06 |
0.0001169 |
115 |
REGULATION OF PHOSPHORUS METABOLIC PROCESS |
26 |
1618 |
2.908e-06 |
0.0001177 |
116 |
REGULATION OF LEUKOCYTE MIGRATION |
8 |
149 |
3.266e-06 |
0.000131 |
117 |
POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
20 |
1036 |
3.416e-06 |
0.0001347 |
118 |
POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
20 |
1036 |
3.416e-06 |
0.0001347 |
119 |
REGULATION OF HYDROLASE ACTIVITY |
23 |
1327 |
3.51e-06 |
0.0001364 |
120 |
CELLULAR RESPONSE TO CYTOKINE STIMULUS |
15 |
606 |
3.517e-06 |
0.0001364 |
121 |
NEGATIVE REGULATION OF TRANSPORT |
13 |
458 |
3.805e-06 |
0.0001463 |
122 |
REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY |
5 |
40 |
3.978e-06 |
0.0001505 |
123 |
POSITIVE REGULATION OF CELL MATRIX ADHESION |
5 |
40 |
3.978e-06 |
0.0001505 |
124 |
PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS |
29 |
1977 |
4.218e-06 |
0.0001583 |
125 |
VASCULATURE DEVELOPMENT |
13 |
469 |
4.922e-06 |
0.0001832 |
126 |
POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS |
5 |
42 |
5.093e-06 |
0.0001881 |
127 |
NEGATIVE REGULATION OF RESPONSE TO STIMULUS |
23 |
1360 |
5.277e-06 |
0.0001934 |
128 |
NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS |
5 |
43 |
5.736e-06 |
0.0002085 |
129 |
RUFFLE ORGANIZATION |
4 |
21 |
6.817e-06 |
0.0002459 |
130 |
DETOXIFICATION |
6 |
77 |
6.891e-06 |
0.0002466 |
131 |
REGULATION OF CELL DIFFERENTIATION |
24 |
1492 |
7.447e-06 |
0.0002645 |
132 |
POSITIVE REGULATION OF CHEMOTAXIS |
7 |
120 |
7.975e-06 |
0.0002811 |
133 |
CALCIUM ION TRANSPORT |
9 |
223 |
8.118e-06 |
0.000284 |
134 |
REGULATION OF CELLULAR EXTRAVASATION |
4 |
22 |
8.293e-06 |
0.000288 |
135 |
POSITIVE REGULATION OF CELL DIFFERENTIATION |
17 |
823 |
8.409e-06 |
0.0002898 |
136 |
CELLULAR RESPONSE TO ENDOGENOUS STIMULUS |
19 |
1008 |
8.703e-06 |
0.0002977 |
137 |
NEGATIVE REGULATION OF NEURON DEATH |
8 |
171 |
9.032e-06 |
0.0003068 |
138 |
POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS |
6 |
81 |
9.25e-06 |
0.0003119 |
139 |
POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE |
8 |
172 |
9.426e-06 |
0.0003155 |
140 |
REGULATION OF LIPID KINASE ACTIVITY |
5 |
48 |
9.962e-06 |
0.0003311 |
141 |
ACTIVATION OF IMMUNE RESPONSE |
12 |
427 |
1.013e-05 |
0.0003344 |
142 |
ORGAN REGENERATION |
6 |
83 |
1.065e-05 |
0.000348 |
143 |
HOMEOSTASIS OF NUMBER OF CELLS |
8 |
175 |
1.069e-05 |
0.000348 |
144 |
RESPONSE TO ABIOTIC STIMULUS |
19 |
1024 |
1.087e-05 |
0.0003512 |
145 |
LYMPHOCYTE MIGRATION |
5 |
49 |
1.104e-05 |
0.0003519 |
146 |
ANGIOGENESIS |
10 |
293 |
1.097e-05 |
0.0003519 |
147 |
PEPTIDYL AMINO ACID MODIFICATION |
17 |
841 |
1.114e-05 |
0.0003527 |
148 |
RESPONSE TO ALCOHOL |
11 |
362 |
1.172e-05 |
0.0003684 |
149 |
POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
10 |
296 |
1.198e-05 |
0.0003743 |
150 |
POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING |
8 |
179 |
1.261e-05 |
0.0003911 |
151 |
DEFENSE RESPONSE |
21 |
1231 |
1.271e-05 |
0.0003916 |
152 |
POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
20 |
1135 |
1.319e-05 |
0.0004038 |
153 |
RESPONSE TO TOXIC SUBSTANCE |
9 |
241 |
1.511e-05 |
0.0004564 |
154 |
EXTRACELLULAR STRUCTURE ORGANIZATION |
10 |
304 |
1.509e-05 |
0.0004564 |
155 |
EPITHELIAL CELL DEVELOPMENT |
8 |
186 |
1.665e-05 |
0.0004998 |
156 |
ENDOTHELIUM DEVELOPMENT |
6 |
90 |
1.698e-05 |
0.0005066 |
157 |
NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS |
7 |
135 |
1.723e-05 |
0.0005108 |
158 |
POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION |
7 |
136 |
1.808e-05 |
0.0005325 |
159 |
RESPONSE TO OXYGEN LEVELS |
10 |
311 |
1.836e-05 |
0.0005373 |
160 |
TISSUE MORPHOGENESIS |
13 |
533 |
1.921e-05 |
0.0005584 |
161 |
POSITIVE REGULATION OF NEUTROPHIL MIGRATION |
4 |
27 |
1.944e-05 |
0.0005584 |
162 |
PHAGOCYTOSIS |
8 |
190 |
1.941e-05 |
0.0005584 |
163 |
NATURAL KILLER CELL ACTIVATION |
5 |
55 |
1.957e-05 |
0.0005587 |
164 |
REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING |
7 |
138 |
1.988e-05 |
0.0005639 |
165 |
REGULATION OF TRANSPORT |
26 |
1804 |
2.036e-05 |
0.0005741 |
166 |
REGULATION OF NEURON APOPTOTIC PROCESS |
8 |
192 |
2.094e-05 |
0.0005868 |
167 |
REGULATION OF NEURON DEATH |
9 |
252 |
2.151e-05 |
0.0005958 |
168 |
OUTFLOW TRACT MORPHOGENESIS |
5 |
56 |
2.139e-05 |
0.0005958 |
169 |
REGULATION OF CELLULAR LOCALIZATION |
21 |
1277 |
2.2e-05 |
0.0006058 |
170 |
RESPONSE TO ACID CHEMICAL |
10 |
319 |
2.283e-05 |
0.0006247 |
171 |
ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY |
8 |
195 |
2.34e-05 |
0.0006368 |
172 |
PLATELET ACTIVATION |
7 |
142 |
2.391e-05 |
0.0006468 |
173 |
REGULATION OF LEUKOCYTE CHEMOTAXIS |
6 |
96 |
2.456e-05 |
0.000658 |
174 |
RESPONSE TO CYTOKINE |
15 |
714 |
2.461e-05 |
0.000658 |
175 |
CELLULAR RESPIRATION |
7 |
143 |
2.501e-05 |
0.0006651 |
176 |
POSITIVE REGULATION OF MAPK CASCADE |
12 |
470 |
2.62e-05 |
0.0006848 |
177 |
REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS |
4 |
29 |
2.607e-05 |
0.0006848 |
178 |
NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT |
4 |
29 |
2.607e-05 |
0.0006848 |
179 |
REGULATION OF T CELL PROLIFERATION |
7 |
147 |
2.987e-05 |
0.0007765 |
180 |
NEGATIVE REGULATION OF LOCOMOTION |
9 |
263 |
3.009e-05 |
0.0007779 |
181 |
REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION |
8 |
203 |
3.12e-05 |
0.0008022 |
182 |
REGULATION OF PHOSPHOLIPID METABOLIC PROCESS |
5 |
61 |
3.253e-05 |
0.0008316 |
183 |
REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION |
6 |
101 |
3.277e-05 |
0.0008332 |
184 |
RESPONSE TO ORGANIC CYCLIC COMPOUND |
17 |
917 |
3.362e-05 |
0.0008503 |
185 |
REGULATION OF CYTOKINE PRODUCTION |
13 |
563 |
3.394e-05 |
0.0008536 |
186 |
REGULATION OF LEUKOCYTE PROLIFERATION |
8 |
206 |
3.464e-05 |
0.0008666 |
187 |
DIVALENT INORGANIC CATION TRANSPORT |
9 |
268 |
3.486e-05 |
0.0008674 |
188 |
REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS |
7 |
152 |
3.701e-05 |
0.0009161 |
189 |
REGULATION OF NEUTROPHIL MIGRATION |
4 |
32 |
3.892e-05 |
0.0009582 |
190 |
REGULATION OF RESPONSE TO WOUNDING |
11 |
413 |
3.941e-05 |
0.0009651 |
191 |
NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
9 |
274 |
4.142e-05 |
0.001009 |
192 |
NEGATIVE REGULATION OF RESPONSE TO WOUNDING |
7 |
156 |
4.369e-05 |
0.001059 |
193 |
DENDRITIC CELL DIFFERENTIATION |
4 |
33 |
4.408e-05 |
0.001063 |
194 |
NATURAL KILLER CELL DIFFERENTIATION |
3 |
12 |
4.455e-05 |
0.001068 |
195 |
POSITIVE REGULATION OF MOLECULAR FUNCTION |
25 |
1791 |
5.162e-05 |
0.001232 |
196 |
POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION |
5 |
68 |
5.512e-05 |
0.001309 |
197 |
INDUCTION OF POSITIVE CHEMOTAXIS |
3 |
13 |
5.766e-05 |
0.001355 |
198 |
EXTRACELLULAR FIBRIL ORGANIZATION |
3 |
13 |
5.766e-05 |
0.001355 |
199 |
CELL SUBSTRATE ADHESION |
7 |
164 |
6.001e-05 |
0.001403 |
200 |
NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION |
4 |
36 |
6.258e-05 |
0.001442 |
201 |
POSITIVE CHEMOTAXIS |
4 |
36 |
6.258e-05 |
0.001442 |
202 |
HEAD MORPHOGENESIS |
4 |
36 |
6.258e-05 |
0.001442 |
203 |
POSITIVE REGULATION OF DEFENSE RESPONSE |
10 |
364 |
6.939e-05 |
0.001591 |
204 |
RESPONSE TO EXTRACELLULAR STIMULUS |
11 |
441 |
7.107e-05 |
0.001619 |
205 |
REGULATION OF INFLAMMATORY RESPONSE |
9 |
294 |
7.131e-05 |
0.001619 |
206 |
ENDOTHELIAL CELL DIFFERENTIATION |
5 |
72 |
7.258e-05 |
0.001632 |
207 |
CHEMOKINE MEDIATED SIGNALING PATHWAY |
5 |
72 |
7.258e-05 |
0.001632 |
208 |
MAMMARY GLAND DEVELOPMENT |
6 |
117 |
7.481e-05 |
0.001673 |
209 |
LYMPHOCYTE CHEMOTAXIS |
4 |
38 |
7.77e-05 |
0.001722 |
210 |
MESENCHYME MORPHOGENESIS |
4 |
38 |
7.77e-05 |
0.001722 |
211 |
VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
5 |
74 |
8.277e-05 |
0.001825 |
212 |
CYTOKINE PRODUCTION |
6 |
120 |
8.61e-05 |
0.00189 |
213 |
CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND |
15 |
799 |
8.818e-05 |
0.001926 |
214 |
ENDOCARDIAL CUSHION FORMATION |
3 |
15 |
9.093e-05 |
0.001932 |
215 |
INNATE IMMUNE RESPONSE |
13 |
619 |
8.899e-05 |
0.001932 |
216 |
POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY |
3 |
15 |
9.093e-05 |
0.001932 |
217 |
VENOUS BLOOD VESSEL DEVELOPMENT |
3 |
15 |
9.093e-05 |
0.001932 |
218 |
MRNA TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
3 |
15 |
9.093e-05 |
0.001932 |
219 |
POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION |
9 |
303 |
8.976e-05 |
0.001932 |
220 |
POSITIVE REGULATION OF CATALYTIC ACTIVITY |
22 |
1518 |
9.169e-05 |
0.001937 |
221 |
INFLAMMATORY RESPONSE |
11 |
454 |
9.198e-05 |
0.001937 |
222 |
OXIDATION REDUCTION PROCESS |
16 |
898 |
9.312e-05 |
0.001952 |
223 |
GLIAL CELL DEVELOPMENT |
5 |
76 |
9.403e-05 |
0.001962 |
224 |
CELLULAR COMPONENT MORPHOGENESIS |
16 |
900 |
9.556e-05 |
0.001985 |
225 |
T CELL DIFFERENTIATION |
6 |
123 |
9.872e-05 |
0.002042 |
226 |
REGULATION OF CHEMOTAXIS |
7 |
180 |
0.0001077 |
0.002217 |
227 |
DENDRITIC CELL CHEMOTAXIS |
3 |
16 |
0.0001114 |
0.002264 |
228 |
MORPHOGENESIS OF AN ENDOTHELIUM |
3 |
16 |
0.0001114 |
0.002264 |
229 |
POSITIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION |
3 |
16 |
0.0001114 |
0.002264 |
230 |
REGULATION OF LEUKOCYTE APOPTOTIC PROCESS |
5 |
79 |
0.0001131 |
0.002288 |
231 |
CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL |
4 |
42 |
0.0001157 |
0.00232 |
232 |
CALCIUM ION IMPORT INTO CYTOSOL |
4 |
42 |
0.0001157 |
0.00232 |
233 |
POSITIVE REGULATION OF LIPID METABOLIC PROCESS |
6 |
128 |
0.000123 |
0.002455 |
234 |
CELLULAR RESPONSE TO OXIDATIVE STRESS |
7 |
184 |
0.0001234 |
0.002455 |
235 |
REGULATION OF GLYCOPROTEIN METABOLIC PROCESS |
4 |
43 |
0.0001269 |
0.002513 |
236 |
NEGATIVE REGULATION OF CELL PROLIFERATION |
13 |
643 |
0.0001299 |
0.002562 |
237 |
NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS |
3 |
17 |
0.0001347 |
0.002645 |
238 |
RESPONSE TO GROWTH FACTOR |
11 |
475 |
0.0001369 |
0.002676 |
239 |
BODY MORPHOGENESIS |
4 |
44 |
0.000139 |
0.002695 |
240 |
NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION |
4 |
44 |
0.000139 |
0.002695 |
241 |
CELL MATURATION |
6 |
131 |
0.0001397 |
0.002696 |
242 |
RESPONSE TO FATTY ACID |
5 |
83 |
0.0001429 |
0.002748 |
243 |
B CELL ACTIVATION |
6 |
132 |
0.0001456 |
0.00278 |
244 |
MYELOID CELL DIFFERENTIATION |
7 |
189 |
0.0001458 |
0.00278 |
245 |
ENDOTHELIAL CELL DEVELOPMENT |
4 |
45 |
0.0001518 |
0.002884 |
246 |
POSITIVE REGULATION OF KINASE ACTIVITY |
11 |
482 |
0.0001555 |
0.002941 |
247 |
RESPONSE TO OXYGEN RADICAL |
3 |
18 |
0.0001609 |
0.003032 |
248 |
DEVELOPMENTAL MATURATION |
7 |
193 |
0.0001659 |
0.003112 |
249 |
POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS |
4 |
47 |
0.0001801 |
0.003366 |
250 |
MYELOID CELL HOMEOSTASIS |
5 |
88 |
0.0001883 |
0.003477 |
251 |
CELLULAR RESPONSE TO INTERLEUKIN 1 |
5 |
88 |
0.0001883 |
0.003477 |
252 |
REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
7 |
197 |
0.0001882 |
0.003477 |
253 |
FIBRIL ORGANIZATION |
3 |
19 |
0.0001903 |
0.0035 |
254 |
REGULATION OF CELL SHAPE |
6 |
139 |
0.000193 |
0.003536 |
255 |
RESPONSE TO NITROGEN COMPOUND |
15 |
859 |
0.0001951 |
0.003555 |
256 |
RESPONSE TO AXON INJURY |
4 |
48 |
0.0001956 |
0.003555 |
257 |
REGULATION OF CELLULAR COMPONENT SIZE |
9 |
337 |
0.0001997 |
0.003613 |
258 |
CELL PROLIFERATION |
13 |
672 |
0.0002003 |
0.003613 |
259 |
RESPONSE TO STEROID HORMONE |
11 |
497 |
0.0002027 |
0.003638 |
260 |
REGULATION OF GTPASE ACTIVITY |
13 |
673 |
0.0002033 |
0.003638 |
261 |
REGULATION OF CELL MATRIX ADHESION |
5 |
90 |
0.0002092 |
0.00373 |
262 |
SECRETION |
12 |
588 |
0.000219 |
0.00389 |
263 |
POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS |
3 |
20 |
0.0002229 |
0.003943 |
264 |
NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT |
6 |
143 |
0.0002251 |
0.003968 |
265 |
FACE DEVELOPMENT |
4 |
50 |
0.0002293 |
0.004027 |
266 |
REGULATION OF KINASE ACTIVITY |
14 |
776 |
0.0002318 |
0.004042 |
267 |
REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL |
5 |
92 |
0.0002319 |
0.004042 |
268 |
REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY |
6 |
145 |
0.0002427 |
0.004213 |
269 |
NEGATIVE REGULATION OF CALCIUM ION TRANSPORT |
4 |
51 |
0.0002477 |
0.004285 |
270 |
ENDOCYTOSIS |
11 |
509 |
0.0002488 |
0.004288 |
271 |
RESPONSE TO ESTRADIOL |
6 |
146 |
0.0002519 |
0.004308 |
272 |
T CELL RECEPTOR SIGNALING PATHWAY |
6 |
146 |
0.0002519 |
0.004308 |
273 |
DENDRITIC CELL MIGRATION |
3 |
21 |
0.0002589 |
0.004397 |
274 |
MRNA TRANSCRIPTION |
3 |
21 |
0.0002589 |
0.004397 |
275 |
NEGATIVE REGULATION OF CELL COMMUNICATION |
18 |
1192 |
0.0002637 |
0.004462 |
276 |
ORGANOPHOSPHATE METABOLIC PROCESS |
15 |
885 |
0.0002687 |
0.004529 |
277 |
REGULATION OF CALCIUM ION TRANSPORT |
7 |
209 |
0.00027 |
0.004536 |
278 |
RESPONSE TO BIOTIC STIMULUS |
15 |
886 |
0.0002719 |
0.004551 |
279 |
MYELOID LEUKOCYTE DIFFERENTIATION |
5 |
96 |
0.0002828 |
0.004683 |
280 |
REGULATION OF CYTOKINE SECRETION |
6 |
149 |
0.000281 |
0.004683 |
281 |
POSITIVE REGULATION OF CYTOKINE SECRETION |
5 |
96 |
0.0002828 |
0.004683 |
282 |
MAMMARY GLAND EPITHELIUM DEVELOPMENT |
4 |
53 |
0.0002876 |
0.004712 |
283 |
AEROBIC RESPIRATION |
4 |
53 |
0.0002876 |
0.004712 |
284 |
CYTOSOLIC CALCIUM ION TRANSPORT |
4 |
53 |
0.0002876 |
0.004712 |
285 |
REGULATION OF INTERFERON GAMMA PRODUCTION |
5 |
97 |
0.0002968 |
0.004845 |
286 |
ENDOCARDIAL CUSHION MORPHOGENESIS |
3 |
22 |
0.0002985 |
0.004851 |
287 |
EMBRYO DEVELOPMENT |
15 |
894 |
0.0002992 |
0.004851 |
288 |
REGULATION OF LIPID METABOLIC PROCESS |
8 |
282 |
0.0003042 |
0.004914 |
289 |
B CELL RECEPTOR SIGNALING PATHWAY |
4 |
54 |
0.0003092 |
0.004978 |
290 |
NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS |
14 |
801 |
0.0003198 |
0.005131 |
291 |
POSITIVE REGULATION OF CELL SUBSTRATE ADHESION |
5 |
99 |
0.0003262 |
0.005217 |
292 |
CELL PROJECTION ORGANIZATION |
15 |
902 |
0.0003289 |
0.005241 |
293 |
POSITIVE REGULATION OF TRANSFERASE ACTIVITY |
12 |
616 |
0.0003342 |
0.005308 |
294 |
POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION |
6 |
154 |
0.0003355 |
0.00531 |
295 |
ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS |
7 |
217 |
0.000339 |
0.005319 |
296 |
REGULATION OF ANTIGEN PROCESSING AND PRESENTATION |
3 |
23 |
0.0003417 |
0.005319 |
297 |
NEGATIVE REGULATION OF INFLAMMATORY RESPONSE |
5 |
100 |
0.0003418 |
0.005319 |
298 |
REGULATION OF SUPEROXIDE METABOLIC PROCESS |
3 |
23 |
0.0003417 |
0.005319 |
299 |
TRABECULA FORMATION |
3 |
23 |
0.0003417 |
0.005319 |
300 |
REGULATION OF APOPTOTIC SIGNALING PATHWAY |
9 |
363 |
0.0003451 |
0.005353 |
301 |
RESPONSE TO ESTROGEN |
7 |
218 |
0.0003485 |
0.005388 |
302 |
NEGATIVE REGULATION OF STEROID METABOLIC PROCESS |
3 |
24 |
0.0003889 |
0.005913 |
303 |
REGULATION OF POSITIVE CHEMOTAXIS |
3 |
24 |
0.0003889 |
0.005913 |
304 |
BLOOD VESSEL ENDOTHELIAL CELL MIGRATION |
3 |
24 |
0.0003889 |
0.005913 |
305 |
EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT |
3 |
24 |
0.0003889 |
0.005913 |
306 |
REGULATION OF T CELL MIGRATION |
3 |
24 |
0.0003889 |
0.005913 |
307 |
REGULATION OF CALCIUM ION IMPORT |
5 |
103 |
0.0003918 |
0.005938 |
308 |
NEGATIVE REGULATION OF CELL ADHESION |
7 |
223 |
0.0003995 |
0.006035 |
309 |
NEGATIVE REGULATION OF WOUND HEALING |
4 |
58 |
0.0004072 |
0.006132 |
310 |
POSITIVE REGULATION OF BIOSYNTHETIC PROCESS |
23 |
1805 |
0.0004125 |
0.006192 |
311 |
RESPONSE TO PROSTAGLANDIN E |
3 |
25 |
0.00044 |
0.006519 |
312 |
CELLULAR EXTRAVASATION |
3 |
25 |
0.00044 |
0.006519 |
313 |
NEGATIVE REGULATION OF CALCIUM ION IMPORT |
3 |
25 |
0.00044 |
0.006519 |
314 |
POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION |
6 |
162 |
0.0004395 |
0.006519 |
315 |
CELL CELL RECOGNITION |
4 |
60 |
0.0004637 |
0.00685 |
316 |
POSITIVE REGULATION OF TRANSPORT |
15 |
936 |
0.0004849 |
0.00714 |
317 |
POSITIVE REGULATION OF LYMPHOCYTE MIGRATION |
3 |
26 |
0.0004952 |
0.007178 |
318 |
NEGATIVE REGULATION OF CATION TRANSMEMBRANE TRANSPORT |
4 |
61 |
0.000494 |
0.007178 |
319 |
VASODILATION |
3 |
26 |
0.0004952 |
0.007178 |
320 |
GLUTATHIONE METABOLIC PROCESS |
4 |
61 |
0.000494 |
0.007178 |
321 |
SCHWANN CELL DEVELOPMENT |
3 |
26 |
0.0004952 |
0.007178 |
322 |
CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND |
10 |
465 |
0.0004979 |
0.007194 |
323 |
RESPONSE TO HYDROGEN PEROXIDE |
5 |
109 |
0.0005082 |
0.00732 |
324 |
POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
17 |
1152 |
0.0005159 |
0.007409 |
325 |
POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING |
4 |
62 |
0.0005256 |
0.007525 |
326 |
REGULATION OF TRANSFERASE ACTIVITY |
15 |
946 |
0.0005414 |
0.007681 |
327 |
WOUND HEALING |
10 |
470 |
0.0005409 |
0.007681 |
328 |
REGULATION OF CELL PROJECTION ORGANIZATION |
11 |
558 |
0.00054 |
0.007681 |
329 |
REGULATION OF BLOOD PRESSURE |
6 |
169 |
0.0005497 |
0.007774 |
330 |
REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY |
3 |
27 |
0.0005546 |
0.007797 |
331 |
REGULATION OF NEUTROPHIL CHEMOTAXIS |
3 |
27 |
0.0005546 |
0.007797 |
332 |
NEGATIVE REGULATION OF GROWTH |
7 |
236 |
0.0005601 |
0.00785 |
333 |
NEGATIVE REGULATION OF CELL GROWTH |
6 |
170 |
0.0005671 |
0.0079 |
334 |
REGULATION OF PROTEIN LOCALIZATION |
15 |
950 |
0.0005656 |
0.0079 |
335 |
REGULATION OF PROTEIN SECRETION |
9 |
389 |
0.0005689 |
0.007902 |
336 |
HEMOSTASIS |
8 |
311 |
0.000582 |
0.00806 |
337 |
TISSUE HOMEOSTASIS |
6 |
171 |
0.0005848 |
0.008075 |
338 |
ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS |
15 |
957 |
0.0006101 |
0.008398 |
339 |
REGULATION OF CELL SUBSTRATE ADHESION |
6 |
173 |
0.0006217 |
0.008533 |
340 |
POSITIVE REGULATION OF ENDOCYTOSIS |
5 |
114 |
0.0006235 |
0.008533 |
341 |
CALCIUM ION IMPORT |
4 |
65 |
0.0006292 |
0.008585 |
342 |
INTERSPECIES INTERACTION BETWEEN ORGANISMS |
12 |
662 |
0.0006343 |
0.008604 |
343 |
SYMBIOSIS ENCOMPASSING MUTUALISM THROUGH PARASITISM |
12 |
662 |
0.0006343 |
0.008604 |
344 |
RESPONSE TO INTERLEUKIN 1 |
5 |
115 |
0.0006488 |
0.008776 |
345 |
REGULATION OF ORGANELLE ORGANIZATION |
17 |
1178 |
0.0006634 |
0.008947 |
346 |
REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT |
5 |
116 |
0.0006748 |
0.009075 |
347 |
REGULATION OF CGMP METABOLIC PROCESS |
3 |
29 |
0.0006868 |
0.009186 |
348 |
REGULATION OF MAP KINASE ACTIVITY |
8 |
319 |
0.000687 |
0.009186 |
349 |
MORPHOGENESIS OF AN EPITHELIUM |
9 |
400 |
0.000694 |
0.009253 |
350 |
NEGATIVE REGULATION OF CYTOPLASMIC TRANSPORT |
5 |
117 |
0.0007016 |
0.009301 |
351 |
IMMUNE EFFECTOR PROCESS |
10 |
486 |
0.0007001 |
0.009301 |
352 |
CELL AGING |
4 |
67 |
0.0007058 |
0.009329 |
353 |
NEGATIVE REGULATION OF MOLECULAR FUNCTION |
16 |
1079 |
0.0007241 |
0.009545 |
354 |
REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN |
4 |
68 |
0.0007464 |
0.009783 |
355 |
TUBE MORPHOGENESIS |
8 |
323 |
0.000745 |
0.009783 |
356 |
HYDROGEN PEROXIDE METABOLIC PROCESS |
3 |
30 |
0.0007598 |
0.009903 |
357 |
REGULATION OF VASCULAR PERMEABILITY |
3 |
30 |
0.0007598 |
0.009903 |